A Prospective Pharmacodynamic Study of Rivaroxaban
NCT01743898
·
clinicaltrials.gov ↗
COMPLETED
Status
65
Enrollment
OTHER
Sponsor class
Conditions
Blood Clot
Interventions
DRUG:
Rivaroxaban
OTHER:
no anticoagulation
Sponsor
University of North Carolina, Chapel Hill